Tradestie Institutional Equity Comparison Engine

RYOJ vs SBC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBC Overall Edge

SBC Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SBC Medical Group Holdings Incorporated Common Stock (SBC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RYOJ trades at N/M Forward P/E with -8.1% operating margin (-34.3% YoY revenue) versus SBC at 10.2x Forward P/E and 39.9% operating margin (+35.1% YoY). In options structure, RYOJ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SBC
RYOJ N/M vs SBC 10.2x Fwd P/E
Growth & Margin Winner SBC
Op Margin -8.1% vs 39.9% ยท YoY -34.3% vs +35.1%
Momentum & Technical Winner SBC
1Y -49.0% vs +76.7% ยท 52W Pos 10% vs 61%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RYOJ NASDAQ
rYojbaba Co., Ltd. Common Shares
Services-Management Consulting Services
$2.23
-0.89% 1D
Market Cap $26.0M
1M Return -11.51%
1Y Return -48.97%
Forward P/E N/M
Unified AI Score
42.9 / 100 HOLD
Tech 23.0 Fund 50.0 Flow 50.0 Mom 64.0
SBC NASDAQ
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.60
-10.69% 1D
Market Cap $643.2M
1M Return +1.08%
1Y Return +76.66%
Forward P/E 10.2x
Unified AI Score
38.7 / 100 SELL
Tech 15.0 Fund 29.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RYOJ -48.97% SBC +76.66% Spread: +126.32 pp (SBC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RYOJ TTM Op. Margin: -8.1% SBC TTM Op. Margin: 39.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RYOJ vs SBC. Trailing 12-month operating profitability (RYOJ -8.1% vs SBC 39.9%) and valuation multiples (RYOJ N/M vs SBC 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RYOJ (2) vs SBC (8)
Institutional Metric RYOJ SBC Criterion Row Winner
Market Capitalization Scale $26.0M $643.2M Larger Scale SBC
Trailing P/E Ratio Valuation N/M 12.3x Lower Multiple SBC
Forward P/E Ratio Valuation N/M 10.2x Lower Multiple SBC
Revenue Growth (YoY) Growth -34.3% +35.1% Higher Growth SBC
Operating Margin (TTM) Profitability -8.1% 39.9% Higher Margin SBC
Net Profit Margin Profitability 1.3% 27.3% Higher Margin SBC
Return on Equity (ROE) Capital Efficiency 2.8% 19.3% Higher ROE SBC
52-Week Range Position Momentum 10% ($2โ€“$8) 61% ($3โ€“$7) Stronger Trend SBC
Beta / 30D Volatility Risk Regime 1.68ฮฒ ยท 92% Vol 0.80ฮฒ ยท 156% Vol Lower Realized Risk RYOJ
Unified Institutional Score Composite Signal 42.9 / 100 (HOLD) 38.7 / 100 (SELL) Higher Composite RYOJ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RYOJ vs SBC Buy Guide
RYOJ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RYOJ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SBC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SBC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RYOJ nor SBC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.